Chemistry:Gemopatrilat
From HandWiki
Short description: Chemical compound
Clinical data | |
---|---|
Other names | BMS-189921 |
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
Chemical and physical data | |
Formula | C19H26N2O4S |
Molar mass | 378.49 g·mol−1 |
3D model (JSmol) | |
| |
|
Gemopatrilat (INN)[1] is an experimental drug that was never marketed.[2] It acts as a vasopeptidase inhibitor.[3][4] It inhibits both angiotensin-converting enzyme (ACE) and neutral endopeptidase (neprilysin).[5]
References
- ↑ "International Nonproprietary Names for Pharmaceutical Substances (INN). Recommended International Nonproprietary Names: List 46". World Health Organization. p. 200. https://www.who.int/medicines/publications/druginformation/innlists/RL64.pdf.
- ↑ "Gemopatrilat". AdisInsight. http://adisinsight.springer.com/drugs/800009581. "Highest Development Phases: Discontinued"
- ↑ "Renoprotective effects of VPI versus ACEI in normotensive nephrotic rats on different sodium intakes". Kidney International 63 (1): 64–71. January 2003. doi:10.1046/j.1523-1755.2003.00708.x. PMID 12472769. https://www.kidney-international.org/article/S0085-2538(15)48845-3/fulltext.
- ↑ "Metabolism of [14C]gemopatrilat after oral administration to rats, dogs, and humans". Drug Metabolism and Disposition 34 (6): 961–70. June 2006. doi:10.1124/dmd.105.007500. PMID 16540589.
- ↑ "In-vitro and in-vivo inhibition of rat neutral endopeptidase and angiotensin converting enzyme with the vasopeptidase inhibitor gemopatrilat". Journal of Hypertension 19 (5): 941–6. May 2001. doi:10.1097/00004872-200105000-00015. PMID 11393678.
Original source: https://en.wikipedia.org/wiki/Gemopatrilat.
Read more |